Non-active Erasca Account

Please join us on Tuesday, April 12th at 4:30 PM EDT for the @Erasca Investor Event featuring Scott Kopetz, M.D., Ph.D., (MD Anderson Cancer Center). A live Q&A session will follow. Register here: lifesci.events/ERAS

.@erascainc is a clinical-stage precision oncology company driven by a bold mission​—to erase cancer. We speak with CEO Jonathan E. Lim, M.D., about the company’s vision. twitter.com/i/broadcasts/1…

Congratulations to @a16z portfolio company Erasca $ERAS on its IPO! @ErascaInc is singularly focused on novel therapies targeting the RAS/MAPK pathway in cancer. Achilles isn’t invincible if you know where to aim your shot. 🎯 #EraseCancer investors.erasca.com/news-releases/…

Welcome to the @Nasdaq family, @erascainc! Erasca, Inc. is a clinical-stage precision oncology company driven by a bold mission: to erase cancer by shutting down one of cancer's most commonly mutated pathways. #EraseCancer Now trading: $ERAS

Behind the scenes at @Nasdaq

It’s been amazing working with Mike Varney as part of the Erasca team. Thank you, NASDAQ, for this recognition! lnkd.in/gpC9Ywx

A big, warm welcome to the @erascainc team! 👏👏👏 Erasca, Inc. joins us in Times Square to ring the @Nasdaq Opening Bell in honor of their IPO. 🎉 #EraseCancer

@Nasdaq We are thrilled to join the #NASDAQ family!